Patent · US Active

Benzazepine compounds, conjugates, and uses thereof

US10519131B2 · kind B2 · utility

6Cited by
6References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 7, 2018
Grant dateDec 31, 2019
Priority date
Expiry dateMay 7, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Benzazepine compounds, conjugates, and pharmaceutical compositions for use in the treatment of disease, such as cancer, are disclosed herein. The disclosed benzazepine compounds are useful, among other things, in the treating of cancer and modulating TLR8. Additionally, benzazepine compounds incorporated into a conjugate with an antibody construct are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.